Literature DB >> 22318126

The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.

Akihiko Nunomura1, Toshio Tamaoki, Nobutaka Motohashi, Masao Nakamura, Daniel W McKeel, Massimo Tabaton, Hyoung-Gon Lee, Mark A Smith, George Perry, Xiongwei Zhu.   

Abstract

Although neuronal RNA oxidation is a prominent and established feature in age-associated neurodegenerative disorders such as Alzheimer disease (AD), oxidative damage to neuronal RNA in aging and in the transitional stages from normal elderly to the onset of AD has not been fully examined. In this study, we used an in situ approachto identify an oxidized RNA nucleoside 8-hydroxyguanosine (8OHG) in the cerebral cortex of 65 individuals without dementia ranging in age from 0.3 to 86 years. We also examined brain samples from 20 elderly who were evaluated for their premortem clinicaldementia rating score and postmortem brain pathologic diagnoses to investigate preclinical AD and mild cognitive impairment. Relative density measurements of 8OHG-immunoreactivity revealed a statistically significant increase in neuronal RNA oxidation during aging in the hippocampus and the temporal neocortex. In subjects with mild cognitive impairment but not preclinical AD, neurons of the temporal cortex showed a higher burden of oxidized RNA compared to age-matched controls. These results indicate that, although neuronal RNA oxidation fundamentally occurs as an age-associated phenomenon, more prominent RNA damage than in normal aging correlates with the onset of cognitive impairment in the prodromal stage of AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318126      PMCID: PMC3288284          DOI: 10.1097/NEN.0b013e318248e614

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  47 in total

1.  Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

Authors:  J L Price; J C Morris
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

2.  Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.

Authors:  William R Markesbery; Richard J Kryscio; Mark A Lovell; Jason D Morrow
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

3.  Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.

Authors:  Kazuhiro Honda; Mark A Smith; Xiongwei Zhu; Diane Baus; William C Merrick; Alan M Tartakoff; Thomas Hattier; Peggy L Harris; Sandra L Siedlak; Hisashi Fujioka; Quan Liu; Paula I Moreira; Frank P Miller; Akihiko Nunomura; Shun Shimohama; George Perry
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

4.  Evidence of increased oxidative damage in subjects with mild cognitive impairment.

Authors:  J N Keller; F A Schmitt; S W Scheff; Q Ding; Q Chen; D A Butterfield; W R Markesbery
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

5.  Quantification of oxidized RNAs in Alzheimer's disease.

Authors:  Xiu Shan; Chien-Liang Glenn Lin
Journal:  Neurobiol Aging       Date:  2005-06-24       Impact factor: 4.673

6.  Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.

Authors:  Jianquan Wang; William R Markesbery; Mark A Lovell
Journal:  J Neurochem       Date:  2006-01-09       Impact factor: 5.372

7.  Hepatic oxidative stress during aging: effects of 8% long-term calorie restriction and lifelong exercise.

Authors:  Arnold Y Seo; Tim Hofer; Bokyung Sung; Sharon Judge; Hae Y Chung; Christiaan Leeuwenburgh
Journal:  Antioxid Redox Signal       Date:  2006 Mar-Apr       Impact factor: 8.401

8.  RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

Authors:  A Nunomura; G Perry; M A Pappolla; R Wade; K Hirai; S Chiba; M A Smith
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

9.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R Markesbery
Journal:  Neurobiol Dis       Date:  2006-02-08       Impact factor: 5.996

10.  Ribosome dysfunction is an early event in Alzheimer's disease.

Authors:  Qunxing Ding; William R Markesbery; Qinghua Chen; Feng Li; Jeffrey N Keller
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

View more
  43 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

Review 2.  Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities.

Authors:  Zhijie Xu; Jinzhou Huang; Ming Gao; Guijie Guo; Shuangshuang Zeng; Xi Chen; Xiang Wang; Zhicheng Gong; Yuanliang Yan
Journal:  Geroscience       Date:  2020-06-11       Impact factor: 7.713

3.  Epigenetic changes in the progression of Alzheimer's disease.

Authors:  M A Bradley-Whitman; M A Lovell
Journal:  Mech Ageing Dev       Date:  2013-09-03       Impact factor: 5.432

4.  High activities of BACE1 in brains with mild cognitive impairment.

Authors:  Xin Cheng; Ping He; Taehee Lee; Hailan Yao; Rena Li; Yong Shen
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

5.  In vivo imaging of prodromal hippocampus CA1 subfield oxidative stress in models of Alzheimer disease and Angelman syndrome.

Authors:  Bruce A Berkowitz; Jacob Lenning; Nikita Khetarpal; Catherine Tran; Johnny Y Wu; Ali M Berri; Kristin Dernay; E Mark Haacke; Fatema Shafie-Khorassani; Robert H Podolsky; John C Gant; Shaniya Maimaiti; Olivier Thibault; Geoffrey G Murphy; Brian M Bennett; Robin Roberts
Journal:  FASEB J       Date:  2017-06-07       Impact factor: 5.191

6.  Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42.

Authors:  Naotaka Izuo; Toshiaki Kume; Mizuho Sato; Kazuma Murakami; Kazuhiro Irie; Yasuhiko Izumi; Akinori Akaike
Journal:  ACS Chem Neurosci       Date:  2012-06-06       Impact factor: 4.418

7.  Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity.

Authors:  Kirstin Aschbacher; Aoife O'Donovan; Owen M Wolkowitz; Firdaus S Dhabhar; Yali Su; Elissa Epel
Journal:  Psychoneuroendocrinology       Date:  2013-03-13       Impact factor: 4.905

Review 8.  Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Anne M Fagan; Richard J Perrin
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

Review 9.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

10.  Evaluation of Eu(II) -based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections.

Authors:  Levi A Ekanger; Lisa A Polin; Yimin Shen; E Mark Haacke; Matthew J Allen
Journal:  Contrast Media Mol Imaging       Date:  2016-03-30       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.